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Objective: Congenital heart defects with a component of pulmonary stenosis are often palliated in childhood by
disrupting the pulmonary valve, either by means of dilation or excision. It is unclear what factors affect a patient’s
ability to tolerate long-term pulmonary insufficiency before requiring pulmonary valve replacement. We analyze
potential factors that are related to the interval between pulmonary valve disruption and pulmonary valve
replacement.
Methods: One hundred seven patients were analyzed. They had a congenital diagnosis of pulmonary stenosis or
tetralogy of Fallot, had their first pulmonary valve replacement between 2002 and 2008, and had a known interval
between pulmonary valve disruption and pulmonary valve replacement. The median age at the time of surgical
intervention was 2 years for pulmonary valve disruption (range, 0–56 years) and 26 years for pulmonary valve
replacement (range, 1–72 years). The median interval was 23 years (range, 0–51 years). Potential related factors
were sex, race, initial diagnosis and procedure, age at pulmonary valve disruption, prior shunt operation, presence
of branch pulmonary artery stenosis, and degree of pulmonary regurgitation.
Results: As determined by using univariate analysis, male patients had a shorter interval than female patients
(median, 16 vs 26 years; P ¼ .01), and African American patients had a shorter interval than white patients (me-
dian, 16 vs 25 years; P¼ .049). A significant correlation was also identified between age at the time of pulmonary
valve disruption and the subsequent interval to pulmonary valve replacement. Overall, the interval tended to in-
crease as age at disruption increased (P<.0001). Although the presence of branch pulmonary artery stenosis de-
termined by the need for concomitant pulmonary arterioplasty was associated with a significantly shorter interval
to pulmonary valve replacement (21 vs 24 years, P¼ .02), stenosis determined based on small branch pulmonary
artery diameter was correlated to a prolonged interval to pulmonary valve replacement (P ¼ .009). Initial diag-
nosis, prior palliative shunt operation, and degree of pulmonary regurgitation had no effect on the interval be-
tween pulmonary valve disruption and subsequent pulmonary valve replacement. As determined by using
multivariate analysis, only male sex and small pulmonary artery diameter remained significant factors.
Conclusions: Male sex appears to shorten the interval between pulmonary valve disruption and pulmonary valve
replacement, whereas small branch pulmonary artery diameter appears to lengthen the interval. Knowing which
factors are detrimental and which are protective might help identify patients who are prone to a more rapid pro-
gression of right heart failure from free pulmonary insufficiency, possibly steering them toward more frequent
follow-up or more aggressive heart failure medical regimens.Surgical management of tetralogy of Fallot and congenital
pulmonary stenosis often results in anatomic and functional
abnormalities: an absent pulmonary valve and free pulmo-
nary insufficiency. Although the right ventricular (RV) vol-
ume load caused by severe pulmonary insufficiency can be
tolerated for years, there is now evidence that the compensa-
tory mechanisms of the RV myocardium will gradually fail.1
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doi:10.1016/j.jtcvs.2009.02.020The Journal of Thoracic andIt is unclear what factors affect a patient’s ability to tolerate
long-term pulmonary insufficiency before requiring pulmo-
nary valve replacement.
MATERIALS AND METHODS
After internal review board approval was obtained, patients who under-
went pulmonary valve replacement were reviewed. They were included in
the analysis if they had a congenital diagnosis of pulmonary stenosis or te-
tralogy of Fallot, if their initial pulmonary valve replacement occurred be-
tween the years 2002 and 2006, and if they had a known interval between
initial valve disruption and valve replacement.
Population Description
Patients had an initial diagnosis of tetralogy of Fallot (n ¼ 90) and con-
genital pulmonary stenosis (n¼ 17). Before the valve-disrupting operation,
29 patients underwent 26 palliative shunting operations. These shunts in-
cluded Blalock–Taussig shunts (n ¼ 24), Potts shunts (n ¼ 4), and Water-
ston shunts (n ¼ 1). The exact type of valve-disrupting operation wasCardiovascular Surgery c Volume 138, Number 1 103
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CMR ¼ cardiac magnetic resonance imaging
LV ¼ left ventricular
PA/BSA ¼ smallest diameter of branch pulmonary
artery identified and indexed to body
surface area
RV ¼ right ventricular
difficult to obtain from old records. With resultant pulmonary insufficiency,
indications for valve replacement surgery included the presence of symp-
toms, decreased RV function, decreased left ventricular (LV) function,
RV/LV end-diastolic volume ratio of greater than 2, QRS duration of greater
than 180 ms, or progressive tricuspid regurgitation (Figure 1). One hundred
three patients received bioprosthetic valves, and 4 received mechanical
valves (Figure 2). Sixty concomitant procedures were performed in 44 pa-
tients (Figure 3). The most common concomitant operations were tricuspid
valve surgery and branch pulmonary arterioplasty (11 on the left and 4 on
the right). No patients have required subsequent pulmonary valve rereplace-
ment. There were 3 surgical mortalities: 1 in a high-risk patient with multi-
ple comorbidities, another in a patient requiring concomitant 3-vessel
coronary bypass, and a third in a patient requiring concomitant aortic valve
and root replacement.
Imaging
Preoperative imaging studies included echocardiography, cardiac cathe-
terization, and cardiac magnetic resonance imaging (CMR). Fifty-eight pa-
tients underwent preoperative CMR. Parameters analyzed were ventricular
chamber size and ratio, ejection fraction, pulmonary regurgitant fraction,
and branch pulmonary artery diameter (Table 1). The smallest branch pul-
monary artery diameter was divided by the patient’s body surface area to ob-
tain the smallest branch pulmonary artery index. Chamber measurements
revealed a median RV end-diastolic volume index of 148 mL/m2 (range,
74–308 mL/m2), an RV end-systolic volume index of 82 mL/m2 (range,
28–195 mL/m2), and an LV end-diastolic volume index of 69 mL/m2
(range, 38–147 mL/m2). The median RV/LV end-diastolic volume ratio
was 1.98 (range, 0.94–3.5). Functional measurements revealed a median
RV ejection fraction of 45% (range, 24%–52%) and an LV ejection frac-
tion of 59% (range, 29%–65%). The median pulmonary regurgitant frac-
tion was 39% (range, 10%–76%). The median smallest branch
pulmonary artery diameter index was 8.8 mm/m2 (range, 1.4–21.6 mm/m2).
The Mann–Whitney test was used to compare 2 groups with respect to
a continuous end point, such as the interval to pulmonary valve replacement.
Binary variables included sex, race, presence of branch pulmonary artery ste-
nosis (determined by concomitant pulmonary arterioplasty at the time of pul-
monary valve replacement), diagnosis, and history of a prior palliative shunt.
Spearman correlation coefficients were calculated to assess the relation-
ship between continuous variables and interval to pulmonary valve replace-
ment. Continuous variables included age, the smallest branch pulmonary
artery determined by using CMR, and regurgitant fraction determined by
using CMR.
A multiple regression model was then used to further evaluate those fac-
tors with a significant relationship to the interval between pulmonary valve
disruption and pulmonary valve replacement.
RESULTS
One hundred seven patients met the study criteria and
were included in the analysis.
Regarding sex, 47 patients were male, and 60 patients
were female. Male patients had a significantly shorter inter-104 The Journal of Thoracic and Cardiovascular Suval to pulmonary valve replacement than female patients
(median, 16 vs 26 years; P ¼ .009; Figure 4).
Regarding race, 23 patients were African American, 82
were white, and 2 were of other racial backgrounds. African
American patients had a shorter interval to pulmonary valve
replacement than white patients (median, 16 vs 25 years;
P ¼ .049; Figure 5).
Regarding age, the median age at the time of surgical inter-
vention was 2 years for pulmonary valve disruption (range,
0–56 years) and 26 years for pulmonary valve replacement
(range, 1–72 years), resulting in a median interval between
pulmonary valve disruption and replacement of 22 years
(range, 0–47). A significant correlation was identified be-
tween age at the time of disruption and the subsequent inter-
val to pulmonary valve replacement. Overall, the pulmonary
valve replacement interval tended to increase as age at dis-
ruption increased (P< .0001).
The presence of branch pulmonary artery stenosis was
initially determined by the need for concomitant pulmonary
arterioplasty at the time of pulmonary valve replacement
and by means of preoperative CMR. During pulmonary
valve replacement, 13 patients underwent pulmonary arte-
rioplasty. By using these criteria, branch pulmonary artery
stenosis was associated with a significantly shorter interval
to pulmonary valve replacement (21 vs 24 years, P ¼ .02,
Figure 6). By using the preoperative magnetic resonance
imaging, the smallest diameter of the branch pulmonary ar-
tery was identified and indexed to the body surface area
(PA/BSA). There was a significant correlation between
PA/BSA and the interval to pulmonary valve replacement.
However, conversely, as the size of the branch pulmonary
arteries decreased, the interval to pulmonary valve replace-
ment increased (P ¼ .009).
Regarding surgical history, 26 patients underwent a sys-
temic–pulmonary artery shunt before their valve-disrupting
procedures. Placement of a shunt before the initial valve dis-
ruption had no effect on the interval between subsequent
pulmonary valve disruption and pulmonary valve replace-
ment (P ¼ .70).
FIGURE 1. Indications for pulmonary valve replacement. RV, Right ven-
tricular; LV, left ventricular; TR, tricuspid regurgitation.rgery c July 2009
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sis and interval to pulmonary valve replacement. Both
groups had a median interval of 23 years (range, 0–51 years
for tetralogy of Fallot and 3–47 years for pulmonary steno-
sis). There was also no correlation between the regurgitant
fraction and the interval to pulmonary valve replacement.
A multivariate regression analysis was performed for sex,
race, age at pulmonary valve disruption, presence of branch
pulmonary stenosis determined by means of concomitant
pulmonary artery plasty, and smallest PA/BSA determined
by means of CMR. Risk factors maintaining significance
were sex and PA/BSA (Table 2).
DISCUSSION
Evaluation
Clinical history, physical examination, electrocardiogra-
phy, and echocardiography are all useful tools in evaluating
pulmonary insufficiency. However, CMR has become the
gold standard imaging modality for the periodic evaluation
and follow-up of patients with pulmonary regurgitation.
Systolic and diastolic flow through the pulmonary valve
FIGURE 2. Pulmonary valve replacement types.
FIGURE 3. Concomitant operations. PA, Pulmonary artery; VSD, ventric-
ular septal defect; ASD, atrial septal defect; AICD, automatic implantable
cardioverter defibrillator; RV, right ventricular; PAPVR, partial anomalous
pulmonary venous return; CABG, coronary artery bypass grafting; PDA,
patent ductus arteriosus.The Journal of Thoracic and Ccan be quantified, allowing for calculation of pulmonary re-
gurgitant fraction. Unlike echocardiography, CMR works
independent of geometric assumptions for evaluation of
RV volume and function and can better assess the branch
pulmonary artery anatomy. Overall, CMR provides essential
and complementary data, facilitating management and prog-
nosis for these patients.2
All of our patients underwent a complete clinical history
and physical examination, electrocardiography, and echo-
cardiography. Potential surgical candidates more than 40
years of age underwent cardiac catheterization for coronary
angiography. Although magnetic resonance imaging is the
diagnostic modality advocated in these patients and our re-
cent trend is for all of patients to undergo CMR, we have
not yet achieved that goal. The patients who did not undergo
CMR before pulmonary valve replacement were primarily
earlier in the study period, our younger patients in whom
CMR would be difficult or would require sedation/intuba-
tion, those with medical devices (pacemakers, coils, stents)
in whom CMR is limited or contraindicated, and those
who met indications for surgical intervention without
CMR whose pulmonary artery anatomy was previously de-
lineated by means of cardiac catheterization.
TABLE 1. Summary of CMR data
Median Range
RV end-diastolic volume index (mL/m2) 148 74–308
RV end-systolic volume index (mL/m2) 82 28–195
LV end-diastolic volume index (mL/m2) 69 38–147
RV/LV end-diastolic volume ratio 1.98 0.94–3.5
RV ejection fraction (%) 45 24–52
LV ejection fraction (%) 59 29–65
Regurgitant fraction (%) 39 10–76
Smallest branch pulmonary artery index (mm/m2) 8.8 1.4–21.6
CMR, Cardiac magnetic resonance imaging; RV, right ventricular; LV, left ventricular.
FIGURE 4. Relationship between sex and interval to pulmonary valve
replacement.ardiovascular Surgery c Volume 138, Number 1 105
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Although the optimal timing of surgical intervention
remains a challenge and decisions need to be made on an
individual basis, pulmonary valve replacement should be
performed in these patients before the development of irre-
versible ventricular dysfunction. Some programs have set
very specific recommendations for pulmonary valve re-
placement in this patient population. These include repaired
tetralogy of Fallot or similar physiology with moderate or se-
vere pulmonary regurgitation (regurgitant fraction>25%, as
measured with CMR) and 2 or more of the following criteria:
(1) RV end-diastolic volume index of 160 mL/m2 or greater,
RV end-systolic volume index of 70 mL/m2 or greater, LV
end-diastolic volume index of 65 mL/m2 or less, RV ejection
fraction of 45% or less, RV outflow tract aneurysm, and
clinical criteria, such as exercise intolerance, symptoms
and signs of heart failure, cardiac medications, syncope,
and sustained ventricular tachycardia.1 The presence of
FIGURE 5. Relationship between race and interval to pulmonary valve
replacement.
FIGURE 6. Relationship between pulmonary artery (PA) plasty and inter-
val to pulmonary valve replacement.106 The Journal of Thoracic and Cardiovascular Surother hemodynamically significant lesions, such as moder-
ate-to-severe tricuspid regurgitation, residual atrial or ven-
tricular septal defects, and severe aortic insufficiency,
also triggered referral for surgical intervention in patients
with moderate or severe pulmonary regurgitation.1
We have been relatively aggressive at recommending pul-
monary valve replacement in these patients, and our criteria
are quite similar to those reported in the literature. They have
remained consistent over the study period and include the
presence of symptoms, decreased RV function, decreased
LV function, RV/LV end-diastolic volume ratio of greater
than 2, QRS duration of greater than 180 ms, and progres-
sive tricuspid regurgitation.
Risk Factors
Regarding sex and race, because patient outcomes are
highly variable despite similar anatomy and hemodynamics,
genetic differences might affect a patient’s ability to tolerate
long-term pulmonary insufficiency before right heart failure
develops and requirement for pulmonary valve replacement.
The interaction between genetic variability and outcome has
been well studied in adult cardiac disease, and common ge-
netic variants in candidate genes of the cardiovascular sys-
tem are likely to play a role in the development of heart
failure, its phenotypic evolution, and, more importantly, its
response to therapeutic intervention.3,4 Although sex differ-
ences remained significant in the univariate and multivariate
analysis, racial differences were barely significant in only
the univariate analysis. Studying the genetic variability in
these patients might be an important area for future research.
Additionally, evaluation of differences in the RV myocar-
dium or pulmonary vasculature between sexes and races
might elucidate some answers as well.
TABLE 2. Multivariate risk factor analysis for shorter interval to
pulmonary valve replacement
Characteristic No.
Mean
interval (y)
Median
interval (y) Correlation
P
value
Male sex
Yes 47 19.3 16 (þ) .003
No 60 25.6 26
African American
Yes 23 18.4 16 .806
No 82 24.3 25
Concomitant branch
PA plasty
Yes 13 15.2 21 .902
No 94 23.9 24
Smallest branch
PA index
() 0.412 () .013
Increased age at
pulmonary valve
disruption
0.3176 .324
PA, Pulmonary artery.gery c July 2009
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anecdotally, that a combination of severe distal pulmonary
artery stenosis and a transannular patch leads to early RV di-
lation and failure.5 RV pressure–volume relationships show
a linear increase in pulmonary regurgitant volume as RV
afterload increases.6 Our analysis showed a significant rela-
tionship between branch pulmonary artery stenosis defined
by performing a concomitant arterioplasty at the time of pul-
monary valve replacement and a shorter interval to pulmo-
nary valve replacement. Unfortunately, the decision to
perform an arterioplasty was not always related to objective
measurements of branch pulmonary artery gradients or sizes,
and the decision was sometimes made intraoperatively based
solely on branch pulmonary artery appearance. This factor
did not remain significant in the multivariate analysis. On
the other hand, pulmonary artery stenosis defined objec-
tively based on branch pulmonary artery size had the oppo-
site effect. It not only prolonged the interval to pulmonary
valve replacement but remained significant in both univari-
ate and multivariate analyses. By using the smallest branch
pulmonary artery diameter measured by means of CMR
and indexing it to body surface area, a significant correlation
was identified between PA/BSA and a longer interval to pul-
monary valve replacement. Interestingly, there was no rela-
tionship between the regurgitant fraction and the interval to
pulmonary valve replacement.
Although it does indeed seem counterintuitive that pul-
monary artery stenosis would somehow be protective and
delay the interval to pulmonary valve replacement, investi-
gation of the RV myocardium might provide insight into
this issue. It is unclear whether there are differences in the
neonatal and adult RV myocardium, and it is unclear
whether changes in the right ventricle that occur from
some degree of pulmonary stenosis (hypertrophy, increased
stiffness, and decreased compliance) might be protective
against the changes that occur from regurgitation.
For those patients who have some degree of residual pul-
monary artery stenosis, it has been suggested that it should
be relieved by balloon dilation, stent implantation, or surgi-
cal intervention if one is to sustain RV function in the very
long term.7,8 However, again it might be that some degree
of pulmonary stenosis (small pulmonary arteries) could re-
sult in changes in the right ventricle that are protective
against RV dilation and the progression of RV failure.
Studies have also shown that surrogates of increased pul-
monary vascular resistance (eg, Waterston or Potts shunts)
are also associated with increased adverse effects of pulmo-
nary regurgitation.9 Our analysis did not identify a relation-
ship between prior systemic–pulmonary artery shunt and
interval to pulmonary valve replacement. Nonetheless,
with early primary repair, these effects are less likely to be
seen in the current era.
Regarding age at disruption, many patients have no sig-
nificant distal pulmonary artery stenosis and no reason forThe Journal of Thoracic andan increased pulmonary arteriolar resistance. Likely, there
is a role of the right ventricle and its ability to modify the in-
fluence of chronic pulmonary incompetence.10 Restrictive
RV physiology has been shown to predict slow postopera-
tive recovery in infants at the time of primary repair.10 In
a study of the same patients at midterm follow-up, the stron-
gest predictor of restrictive RV physiology was restrictive
physiology in the postoperative period.11 The implication
of restrictive physiology is that the diastolic compliance of
the right ventricle is reduced. Therefore the stiff and poorly
compliant right ventricle will not react in the same way to the
potential chronic overload of pulmonary regurgitation. Al-
though the reaction of the normal right ventricle is progres-
sive dilation in response to pulmonary regurgitation, this
normal physiology is lost when the right ventricle is restric-
tive.12 Although this appears to be disadvantageous in the
early postoperative period, restrictive physiology has many
potential advantages during late postoperative follow-up.
In a study of late survivors, restrictive physiology was asso-
ciated with a smaller heart on chest radiographic analysis,
improved exercise function on formal treadmill testing,
and a shorter QRS duration on the resting electrocardio-
gram.13
Contemporary patients often undergo primary repair at
presentation or when they become symptomatic.14,15 Along
with abolishing cyanosis and promoting pulmonary artery
growth, another stated aim of ever earlier surgical repair
has been the preservation of RV performance. However,
they might, paradoxically, be exposed to a much greater
risk of the effects of pulmonary incompetence than the ear-
lier cohorts and operated on much later in life and with much
more intrinsic and postoperative diastolic disease.7 With this
in mind, there might indeed be some benefit in delaying the
primary repair in some patients.
CONCLUSION
Many questions still remain, and unfortunately, the results
of our current treatment strategy will not be realized for
many years. However, by identifying the risk factors that af-
fect the progression of right heart failure from pulmonary in-
sufficiency, hopefully we can begin to affect change to
gradually lengthen the interval between pulmonary valve
disruption and pulmonary valve replacement.
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